Vasala et al. [10, 54], using ELISA, determined that high serum levels of circulating pro-MMP-2 and TIMP-2 are associated with a better clinical course; moreover, total pro-MMP-2 was found to be an independent prognostic marker of bladder cancer progression. This evidence concerns the gene MMP2 and urinary bladder carcinoma.